Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model. (2020)
Attributed to:
The role of P2X7 in Autoimmune Vasculitis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.kint.2019.12.014
PubMed Identifier: 32305129
Publication URI: http://europepmc.org/abstract/MED/32305129
Type: Journal Article/Review
Volume: 97
Parent Publication: Kidney international
Issue: 6
ISSN: 0085-2538